Hinge Health, Inc. Income Statement
HNGE / Information Technology|3 years of annual SEC 10-K data (FY2023-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 3 fiscal years. All figures from audited SEC 10-K filings.
Hinge Health, Inc. reported $588M in revenue and $528M in net loss for FY2025. Revenue has grown at a 41.7% compound annual rate over the past 2 years.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.39 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $587.9M | $390.4M | $292.7M |
| Cost of Revenue | $119.6M | $90.5M | $98.6M |
| Gross Profit | $468.2M | $299.9M | $194.2M |
| SG&A Expense | $329.5M | $63.9M | $67.0M |
| R&D Expense | $368.1M | $100.8M | $110.1M |
| Operating Income | -$546.4M | -$31.9M | -$130.5M |
| Income Tax | $998.0K | $677.0K | -$405.0K |
| Net Income | -$528.3M | -$11.9M | -$108.1M |
| EPS (Basic) | -$8.31 | -$0.88 | -$8.31 |
| EPS (Diluted) | -$8.31 | -$0.88 | -$8.31 |
| Shares Outstanding | 16.4M | 13.6M | 13.0M |
| Gross Margin | 79.7% | 76.8% | 66.3% |
| Operating Margin | -92.9% | -8.2% | -44.6% |
| Profit Margin | -89.9% | -3.1% | -36.9% |